Ikarian Capital, LLC 13F Holdings
CIK 0001778253 · DALLAS, TX
As of Sep 30, 2025, Ikarian Capital, LLC reported 139 positions worth $990.4M in its SEC Form 13F filing.
Top 25 holdings
| Security | Ticker | Sector | Shares | Value | % of portfolio |
|---|---|---|---|---|---|
| UNITED THERAPEUTICS CORP | UTHR | Healthcare | 212,100 | $88.9M | 8.98% |
| STATE STREET(R) SPDR(R) S&P(R) BIOTECH ETF | XBI | — | 750,000 | $75.2M | 7.59% |
| GENMAB A | GMAB | Healthcare | 175,000 | $53.0M | 5.35% |
| BRISTOL MYERS SQUIBB CO | BMY | Healthcare | 800,000 | $36.1M | 3.64% |
| ABIVAX SA | ABVX | Healthcare | 396,098 | $33.4M | 3.37% |
| UNIQURE NV | — | — | 535,600 | $31.3M | 3.16% |
| INSMED INC | INSM | Healthcare | 213,751 | $30.8M | 3.11% |
| PTC THERAPEUTICS INC | PTCT | Healthcare | 493,551 | $30.3M | 3.06% |
| IONIS PHARMACEUTICALS INC | IONS | Healthcare | 428,463 | $28.0M | 2.83% |
| CIDARA THERAPEUTICS INC | CDTX | Healthcare | 277,704 | $26.6M | 2.69% |
| SCHOLAR ROCK HOLDING CORP | SRRK | Healthcare | 657,800 | $24.5M | 2.47% |
| RAPT THERAPEUTICS INC | RAPT | Healthcare | 790,000 | $20.4M | 2.06% |
| MAZE THERAPEUTICS INC | MAZE | Healthcare | 740,825 |